Talk:Systemic lupus erythematosus

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
WikiProject Medicine / Dermatology  (Rated B-class, High-importance)
WikiProject iconThis article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.
B-Class article B  This article has been rated as B-Class on the project's quality scale.
 High  This article has been rated as High-importance on the project's importance scale.
Taskforce icon
This article is supported by the Dermatology task force (marked as High-importance).
Note icon
Information from this article appears on Portal:Medicine in the Did you know section.
Note icon
This article was previously a Medicine Collaboration of the Week.

Ethnic frequencies[edit]

African-American women are three times more likely than Caucasian women to get lupus and develop severe symptoms, with as many as 1 in every 250 affected.

And the disease is two times more prevalent in Asian-American and Latina women than it is in Caucasian women. Women of Native American descent are also disproportionately affected.

The famous Lupus in Minorities: Nature Versus Nurture (LUMINA) study—a large multi-ethnic, multi-regional, and multi-institutional examination of lupus begun in 1993—found that genetic and ethnic factors are more important than socioeconomic ones in influencing disease activity. — Preceding unsigned comment added by Nbauman (talkcontribs) 23:04, 24 August 2015 (UTC)

Treatment: cyclophosphamide[edit]

Because of potential side-effects, cyclophosphamide (CYC) is used in early phases of treatment for severe cases and substituted with other medications for maintenance therapy.[1]


  1. ^ Davis, LS; Reimold, AM (1 April 2017). "Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus". Rheumatology (Oxford, England). 56 (suppl_1): i100–i113. doi:10.1093/rheumatology/kew417. PMID 28375452.

— Preceding unsigned comment added by Winelibrarian (talkcontribs) 15:55, 17 January 2019 (UTC)

Treatment option clarification[edit]

Treatment option clarification: following "There is no cure for SLE.[1] Treatments may include NSAIDs, corticosteroids, immunosuppressants, hydroxychloroquine, and methotrexate.[1]"

insert: Corticosteroids is one of the most effective therapies resulting in immediate mitigation of inflammation. Long term use of corticosteroids results in significant side-effects. [1] --Swozingram (talk) 23:03, 19 September 2019 (UTC)

Okay ref says "CSs are one of the most effective therapies for immediately dampening inflammation; however, long-term use of CSs can cause serious side-effects"
Will add but paraphrase more.

Doc James (talk · contribs · email) 00:17, 20 September 2019 (UTC)